203 related articles for article (PubMed ID: 21252497)
1. E109K is a SEC23B founder mutation among Israeli Moroccan Jewish patients with congenital dyserythropoietic anemia type II.
Amir A; Dgany O; Krasnov T; Resnitzky P; Mor-Cohen R; Bennett M; Berrebi A; Tamary H
Acta Haematol; 2011; 125(4):202-7. PubMed ID: 21252497
[TBL] [Abstract][Full Text] [Related]
2. Two founder mutations in the SEC23B gene account for the relatively high frequency of CDA II in the Italian population.
Russo R; Gambale A; Esposito MR; Serra ML; Troiano A; De Maggio I; Capasso M; Luzzatto L; Delaunay J; Tamary H; Iolascon A
Am J Hematol; 2011 Sep; 86(9):727-32. PubMed ID: 21850656
[TBL] [Abstract][Full Text] [Related]
3. [Congenital dyserythropoietic anemia type II: a case report and literature review].
Li Y; Zhao X; Zhou K; Li Y; Li JP; Ye L; Peng GX; Fan HH; Jing LP; Zhang L; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2012 Apr; 33(4):270-3. PubMed ID: 22781715
[TBL] [Abstract][Full Text] [Related]
4. Congenital dyserythropoietic anemia type II in a newborn with a novel compound heterozygous mutation in the SEC23B: a case report and review of the literature.
Zheng J; Gao L; Liu H; Xiao P; Lu J; Li J; Wu S; Cheng S; Bian X; Du Z; Kong L; Hu S; Fan J
Int J Hematol; 2024 Feb; 119(2):210-214. PubMed ID: 38127226
[TBL] [Abstract][Full Text] [Related]
5. Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B gene.
Bianchi P; Fermo E; Vercellati C; Boschetti C; Barcellini W; Iurlo A; Marcello AP; Righetti PG; Zanella A
Hum Mutat; 2009 Sep; 30(9):1292-8. PubMed ID: 19621418
[TBL] [Abstract][Full Text] [Related]
6. New Cases and Mutations in
Musri MM; Venturi V; Ferrer-Cortès X; Romero-Cortadellas L; Hernández G; Leoz P; Ricard Andrés MP; Morado M; Fernández Valle MDC; Beneitez Pastor D; Ortuño Cabrero A; Moreno Gamiz M; Senent Peris L; Perez-Valencia AI; Pérez-Montero S; Tornador C; Sánchez M
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373084
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Novel Mutation in the SEC23B Gene Associated With Congenital Dyserythropoietic Anemia Type II Through the Use of Next-generation Sequencing Panel in an Undiagnosed Case of Nonimmune Hereditary Hemolytic Anemia.
Aydin Koker S; Karapinar TH; Oymak Y; Bianchi P; Fermo E; Gozmen S; Vergin C
J Pediatr Hematol Oncol; 2018 Oct; 40(7):e421-e423. PubMed ID: 29846281
[TBL] [Abstract][Full Text] [Related]
8. Compound heterozygosity for two novel mutations of the SEC23B gene in congenital dyserythropoietic anemia type II.
Chen S; Guo Z; Ye Y; Yang S; Huang G
Int J Hematol; 2021 Sep; 114(3):390-394. PubMed ID: 33914262
[TBL] [Abstract][Full Text] [Related]
9. Congenital dyserythropoietic anemia in China: a case report from two families and a review.
Ru Y; Liu G; Bai J; Dong S; Nie N; Zhang H; Zhao S; Zheng Y; Zhu X; Nie G; Zhang F; Eyden B
Ann Hematol; 2014 May; 93(5):773-7. PubMed ID: 24196372
[TBL] [Abstract][Full Text] [Related]
10. Congenital dyserythropoietic anemia type II: molecular analysis and expression of the SEC23B gene.
Punzo F; Bertoli-Avella AM; Scianguetta S; Della Ragione F; Casale M; Ronzoni L; Cappellini MD; Forni G; Oostra BA; Perrotta S
Orphanet J Rare Dis; 2011 Dec; 6():89. PubMed ID: 22208203
[TBL] [Abstract][Full Text] [Related]
11. RAP-011 Rescues the Disease Phenotype in a Cellular Model of Congenital Dyserythropoietic Anemia Type II by Inhibiting the SMAD2-3 Pathway.
De Rosa G; Andolfo I; Marra R; Manna F; Rosato BE; Iolascon A; Russo R
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759740
[TBL] [Abstract][Full Text] [Related]
12. Congenital dyserythropoietic anemia, type II with SEC23B exon 12 c.1385 A → G mutation, and pseudo-Gaucher cells in two siblings.
Sharma P; Das R; Bansal D; Trehan A
Hematology; 2015 Mar; 20(2):104-7. PubMed ID: 24801240
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of 42 patients with congenital dyserythropoietic anemia type II: new mutations in the SEC23B gene and a search for a genotype-phenotype relationship.
Iolascon A; Russo R; Esposito MR; Asci R; Piscopo C; Perrotta S; Fénéant-Thibault M; Garçon L; Delaunay J
Haematologica; 2010 May; 95(5):708-15. PubMed ID: 20015893
[TBL] [Abstract][Full Text] [Related]
14. Homozygosity mapping reveals founder SEC23B-Y462C mutations in Indian congenital dyserythropoietic anemia type II.
Singleton B; Bansal D; Varma N; Das R; Naseem S; Saikia UN; Malhotra P; Varma S; Marwaha RK; King MJ; Ahmed M
Clin Genet; 2015 Aug; 88(2):195-7. PubMed ID: 25418799
[No Abstract] [Full Text] [Related]
15. Congenital dyserythropoietic anemia type II mimicking hereditary spherocytosis in Indian patient with SEC23B-Y462C mutations.
Kedar P; Parmar V; Devendra R; Gupta V; Warang P; Madkaikar M
Ann Hematol; 2017 Dec; 96(12):2135-2139. PubMed ID: 28879554
[No Abstract] [Full Text] [Related]
16. Retrospective cohort study of 205 cases with congenital dyserythropoietic anemia type II: definition of clinical and molecular spectrum and identification of new diagnostic scores.
Russo R; Gambale A; Langella C; Andolfo I; Unal S; Iolascon A
Am J Hematol; 2014 Oct; 89(10):E169-75. PubMed ID: 25044164
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis: Congenital Dyserythropoietic Anemia Type 2 Due to Compound Heterozygote Mutation in SEC23B Gene.
Demircioğlu F; Erkoçoğlu M; Dilek M; Bekdaş M; Göksügür S; Büyükkorkmaz S; Açar S
Turk J Haematol; 2015 Sep; 32(3):283-4. PubMed ID: 25912935
[No Abstract] [Full Text] [Related]
18. [Diagnosis and genetics of congenital dyserythropoietic anemias (CDA)].
Rössler J; Havers W
Klin Padiatr; 2000; 212(4):153-8. PubMed ID: 10994542
[TBL] [Abstract][Full Text] [Related]
19. Congenital dyserythropoietic anemias: epidemiology, clinical significance, and progress in understanding their pathogenesis.
Heimpel H
Ann Hematol; 2004 Oct; 83(10):613-21. PubMed ID: 15278299
[TBL] [Abstract][Full Text] [Related]
20.
Alam MJ; Mandal AK; Mandal S; Jana JK
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35820731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
